In a few recent studies in MM, mostly p53-related signaling pathway has been found modulated by miRNAs in the context of drugs suggesting a possible mechanism of miRNAs in regulation of drug response in MM cells (Table 1). The gene discussed is TP53; the disease is Miyoshi myopathy.